These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35576217)

  • 1. Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
    Dublin S; Idu A; Avalos LA; Cheetham TC; Easterling TR; Chen L; Holt VL; Nance N; Bider-Canfield Z; Neugebauer RS; Reynolds K; Badon SE; Shortreed SM
    PLoS One; 2022; 17(5):e0268284. PubMed ID: 35576217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    BJOG; 2014 Aug; 121(9):1090-6. PubMed ID: 24628701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():124-8. PubMed ID: 24502872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension.
    Sanusi AA; Leach J; Boggess K; Dugoff L; Sibai B; Lawrence K; Hughes BL; Bell J; Aagaard K; Edwards RK; Gibson KS; Haas DM; Plante L; Metz TD; Casey B; Esplin S; Longo S; Hoffman MK; Saade GR; Hoppe KK; Foroutan J; Tuuli M; Owens MY; Simhan HN; Frey H; Rosen T; Palatnik A; Baker S; August P; Reddy UM; Su EJ; Krishna I; Nguyen NA; Norton ME; Skupski D; El-Sayed YY; Ogunyemi D; Galis ZS; Harper L; Ambalavanan N; Geller NL; Kuo HC; Sinkey RG; Librizzi R; Pereira L; Magann EF; Habli M; Williams S; Mari G; Pridjian G; McKenna DS; Parrish M; Chang E; Osmundson S; Quinones J; Szychowski JM; Tita ATN
    Obstet Gynecol; 2024 Jul; 144(1):126-134. PubMed ID: 38949541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes.
    Sweeney LC; Lundsberg LS; Culhane JF; Partridge C; Son M
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2305675. PubMed ID: 38290827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?
    Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM;
    Hypertension; 2016 Nov; 68(5):1153-1159. PubMed ID: 27620393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds.
    Avalos LA; Neugebauer RS; Nance N; Badon SE; Cheetham TC; Easterling TR; Reynolds K; Idu A; Bider-Canfield Z; Holt VL; Dublin S
    Pharmacotherapy; 2023 May; 43(5):381-390. PubMed ID: 36779861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011.
    Fisher SC; Van Zutphen AR; Romitti PA; Browne ML;
    Matern Child Health J; 2018 Feb; 22(2):237-246. PubMed ID: 29124624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
    Abalos E; Duley L; Steyn DW; Gialdini C
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and perinatal outcomes of extreme obesity in pregnancy.
    Crane JM; Murphy P; Burrage L; Hutchens D
    J Obstet Gynaecol Can; 2013 Jul; 35(7):606-611. PubMed ID: 23876637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
    Bellos I; Pergialiotis V; Papapanagiotou A; Loutradis D; Daskalakis G
    Am J Obstet Gynecol; 2020 Oct; 223(4):525-537. PubMed ID: 32199925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy.
    Sibai BM; Mabie WC; Shamsa F; Villar MA; Anderson GD
    Am J Obstet Gynecol; 1990 Apr; 162(4):960-6; discussion 966-7. PubMed ID: 2183619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study.
    Vigod SN; Kurdyak PA; Dennis CL; Gruneir A; Newman A; Seeman MV; Rochon PA; Anderson GM; Grigoriadis S; Ray JG
    BJOG; 2014 Apr; 121(5):566-74. PubMed ID: 24443970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records.
    Al Khalaf S; Khashan AS; Chappell LC; O'Reilly ÉJ; McCarthy FP
    Hypertension; 2022 Jul; 79(7):1548-1558. PubMed ID: 35502665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
    Rezk M; Emarh M; Masood A; Dawood R; El-Shamy E; Gamal A; Badr H
    Hypertens Pregnancy; 2020 Nov; 39(4):393-398. PubMed ID: 32697618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.